Update On Antibody-Drug Conjugates (ADCs) For MBC
Antibody-drug conjugates consist of an antibody attached to a chemotherapy drug that delivers chemotherapy only where it is needed, limiting unwanted side...
Read MoreAll About Phase II Clinical Trials
Last month, we highlighted what to know about phase I clinical trials. In the second of our four-part series, we are discussing phase II clinical trials. Phase II...
Read MoreWhy Does The Same Drug Work Differently In Different People?
Your body makes many enzymes that can break down or activate the drugs you take. These enzymes are produced from genes that you inherited from your parents. These...
Read MoreWhen We Tri(al) Our New Partner!
Our newest Metastatic Trial Search partner is WhenWeTrial.org. When We Tr(ial) is a collaboration between TOUCH, The Black Breast Cancer Alliance and...
Read MoreVirtual Conferences: How Do I Prepare?
Breast cancer conferences are currently in-person, virtual, or hybrid (both in-person and virtual). Conferences, regardless of the setting, are often free for...
Read MoreAll About Phase I Clinical Trials
Prior to FDA approval, the safety and effectiveness of drugs are tested in three main phases of clinical trials: phase I, II, and III. Phase I clinical trials...
Read MoreMale MBC Treatment And Clinical Trials
Over 2,700 men will be diagnosed with invasive breast cancer this year, and about 90% of male breast cancer is hormone-receptor-positive (ER+ and/or PR+). Doctors...
Read MoreMBCBrainMets.org – Our New Partner!
Our newest Metastatic Trial Search partner is MBCBrainMets.org. The new website was recently launched to fill an unmet need for information and support for people...
Read MoreBispecific Antibodies: An Emerging Class Of MBC Drugs
Bispecific antibodies are an emerging class of drugs in breast cancer clinical research. By binding to two distinct targets, a bispecific antibody can do two jobs...
Read MoreSEARCH OUR SITE
for past articles or specific information.